NCT05197946

Brief Summary

The investigators hope to use MRI biomarkers to identify and characterize sensorimotor network disruption patterns associated with chronic pain and sensory deficits in CP. Investigators will use existing information in the medical record as well as subjective reports from interview, physical exam data, and anatomical and functional MRI data to non-invasively identify brain injury correlates of pain and sensory deficits.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2018

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 4, 2018

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

December 14, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 20, 2022

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2026

Completed
Last Updated

May 2, 2025

Status Verified

May 1, 2025

Enrollment Period

7.3 years

First QC Date

December 14, 2021

Last Update Submit

May 1, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Regional brain/spine volumes

    Regional volumes will be measured using MR processing software

    <3 months

  • Diffusion scalars

    Diffusion scalars for tracts of interest including the posterior thalamic radiations as well as somatosensory association fibers and the spinothalamic tract

    <3 months

Study Arms (4)

Participants with CP (survey-only)

Subjects in this group are age 8 and older with a diagnosis of cerebral palsy. Participants are either able to affirmatively consent or assent with LAR consent. This sample will have a CFCS score ranging between 1 and 3 and should be able to unambiguously respond to a 65 item multiple choice survey.

Neurotypical participants (survey-only)

Subjects in this group are age 8 and older with no clinically significant neurologic or developmental diagnosis. Participants are either able to affirmatively consent or assent with LAR consent.

Participants with CP (Survey + MRI)

Subjects are 8 years or older with a diagnosis of cerebral palsy and clinical imaging demonstrating isolated periventricular white matter injury. Clinical assessment states that neurologic symptoms are attributed to this isolated injury. Subjects in this group must be able to lie still in a scanner for 1.5 hours in at most 2 sessions and be able to have an MRI. Participants must be able to affirmatively consent or assent with LAR consent.

Diagnostic Test: MRI

Neurotypical participants (Survey + MRI)

Subjects in this group are age 8 and older with no clinically significant neurologic or developmental diagnosis. Participants are able to affirmatively consent and are able to have an MRI. Subjects also should be able to lie still in a scanner for 1.5 hours.

Diagnostic Test: MRI

Interventions

MRIDIAGNOSTIC_TEST

Research unsedated MRI scans (outside of usual care) will be performed using a 3T Philips scanner at the F.M. Kirby Research Center. An MRI scanning protocol will be at the F.M. Kirby Research Center; the protocol will not last more than 1.5 hours. Acquisitions will include a triplanar survey, functional and anatomical multi-slice imaging of the brain as well as MRI of selected spinal levels. Protocols will be used that do not involve use of contrast agents and limit power/tissue absorption as well as otherwise remain within FDA and Kirby Center safety regulations. When possible, MRI will be performed within 3 months of initial survey/interview administration. If MRI is scheduled \>3 months after initial survey/interview administration, a brief survey will be re-administered to screen for changes in pain/clinical status.

Neurotypical participants (Survey + MRI)Participants with CP (Survey + MRI)

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Children and adults with cerebral palsy and typically-developing adults and children

You may qualify if:

  • Individual 8+ years of age
  • Diagnosis of cerebral palsy

You may not qualify if:

  • None
  • Neurotypical participants: (Survey-only):
  • Individual 8+ years of age
  • Adult subject able to indicate understanding and affirmative consent OR Adult/child subject unable to indicate understanding and affirmative consent AND subject assents AND LAR consents
  • Clinically-significant neurologic or developmental diagnosis
  • Participants with CP (Survey and MRI):
  • Individual 8+ years of age
  • Adult subject able to indicate understanding and affirmative consent OR Adult subject unable to indicate understanding and affirmative consent AND subject assents AND LAR consents
  • Diagnosis of cerebral palsy
  • Clinical imaging demonstrating isolated periventricular white matter injury
  • Clinical judgment that all neurologic symptoms are attributable to non-progressive periventricular white matter injury
  • Able to lie still in scanner for 1.5 hours in at most 2 sessions and be able to have MRI
  • None
  • Neurotypical participants (Survey and MRI):
  • Individual 8+ years of age
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

F.M. Kirby Center

Baltimore, Maryland, 21205, United States

RECRUITING

Mt. Washington Pediatric Hospital

Baltimore, Maryland, 21209, United States

RECRUITING

Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States

RECRUITING

Kennedy Krieger Institute

Baltimore, Maryland, 21287, United States

RECRUITING

MeSH Terms

Conditions

Cerebral PalsyChronic Pain

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Eric Chin, MD

    Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2021

First Posted

January 20, 2022

Study Start

December 4, 2018

Primary Completion

April 7, 2026

Study Completion

April 7, 2026

Last Updated

May 2, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations